Skip to main content
. 2018 Oct 26;21(Suppl Suppl 8):e25187. doi: 10.1002/jia2.25187

Abstract P138 – Table 1. Baseline demographic and laboratory characteristics of the study patients

Characteristics Raltegravir Elvitegravir Dolutegravir p value
Patient, n 28 29 32 0.3675
Gender (F), n (%) 26 (93) 26 (90) 27 (84) 0.3549
Age, median years (range) 41 (19 to 80) 41 (22 to 73) 42 (21 to 65) 0.9391
Baseline CD4 +  T‐cell count, median (range) 417 (12 to 1215) 353 (9 to 1218) 376 (8 to 819) 0.6331
Baseline CD4/CD8 ratio, median (range) 0.42 (0.01 to 1.33) 0.44 (0.01 to 1.5) 0.44 (0.03 to 1.15) 0.9513
Baseline HIV‐1 RNA load, median copies/mL (range) 2.5 + E5 (5 + E3‐2.4 E6) 3.3 + E5 (1.4 + E3‐6.6 + E6) 7.9 + E5 (6.5 + E3‐7.8 + E6) 0.2669